These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 10927028

  • 1. Inhibition of neuronal nitric oxide synthase activity by 3-[2-[4-(3-chloro-2-methylphenyl)- 1-piperazinyl]ethyl]-5, 6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate (DY-9760e), a novel neuroprotective agent, in vitro and in cultured neuroblastoma cells in situ.
    Fukunaga K, Ohmitsu M, Miyamoto E, Sato T, Sugimura M, Uchida T, Shirasaki Y.
    Biochem Pharmacol; 2000 Sep 01; 60(5):693-9. PubMed ID: 10927028
    [Abstract] [Full Text] [Related]

  • 2. The post-ischemic administration of 3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate (DY-9760e), a novel calmodulin antagonist, prevents delayed neuronal death in gerbil hippocampus.
    Hashiguchi A, Yano S, Morioka M, Hamada J, Shirasaki Y, Kochi M, Fukunaga K.
    J Pharmacol Sci; 2004 Sep 01; 96(1):65-72. PubMed ID: 15359085
    [Abstract] [Full Text] [Related]

  • 3. The neuroprotective effect of a novel calmodulin antagonist, 3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate, in transient forebrain ischemia.
    Hashiguchi A, Kawano T, Yano S, Morioka M, Hamada J, Sato T, Shirasaki Y, Ushio Y, Fukunaga K.
    Neuroscience; 2003 Sep 01; 121(2):379-86. PubMed ID: 14521996
    [Abstract] [Full Text] [Related]

  • 4. DY-9760e, a novel calmodulin antagonist with cytoprotective action.
    Sugimura M, Sato T, Nakayama W, Morishima Y, Fukunaga K, Omitsu M, Miyamoto E, Shirasaki Y.
    Eur J Pharmacol; 1997 Oct 01; 336(1):99-106. PubMed ID: 9384259
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of dystrophin breakdown and endothelial nitric-oxide synthase uncoupling accounts for cytoprotection by 3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate (DY-9760e) in left ventricular hypertrophied Mice.
    Han F, Lu YM, Hasegawa H, Kanai H, Hachimura E, Shirasaki Y, Fukunaga K.
    J Pharmacol Exp Ther; 2010 Feb 01; 332(2):421-8. PubMed ID: 19889795
    [Abstract] [Full Text] [Related]

  • 6. 3-[2-[4-(3-Chloro-2-methylphenylmethyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydro-chloride 3.5 hydrate (DY-9760e) is neuroprotective in rat microsphere embolism: role of the cross-talk between calpain and caspase-3 through calpastatin.
    Han F, Shirasaki Y, Fukunaga K.
    J Pharmacol Exp Ther; 2006 May 01; 317(2):529-36. PubMed ID: 16467455
    [Abstract] [Full Text] [Related]

  • 7. 3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate (DY-9760e), a novel calmodulin antagonist, reduces brain edema through the inhibition of enhanced blood-brain barrier permeability after transient focal ischemia.
    Sato T, Morishima Y, Shirasaki Y.
    J Pharmacol Exp Ther; 2003 Mar 01; 304(3):1042-7. PubMed ID: 12604680
    [Abstract] [Full Text] [Related]

  • 8. DY-9760e, a novel calmodulin inhibitor, exhibits cardioprotective effects in the ischemic heart.
    Fukunaga K, Han F, Shioda N, Moriguchi S, Kasahara J, Shirasaki Y.
    Cardiovasc Drug Rev; 2006 Mar 01; 24(2):88-100. PubMed ID: 16961723
    [Abstract] [Full Text] [Related]

  • 9. In vitro metabolism of the calmodulin antagonist DY-9760e (3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate) by human liver microsomes: involvement of cytochromes p450 in atypical kinetics and potential drug interactions.
    Tachibana S, Fujimaki Y, Yokoyama H, Okazaki O, Sudo K.
    Drug Metab Dispos; 2005 Nov 01; 33(11):1628-36. PubMed ID: 16049129
    [Abstract] [Full Text] [Related]

  • 10. Cytoprotective effect of 3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate (DY-9760e) against ischemia/reperfusion-induced injury in rat heart involves inhibition of fodrin breakdown and protein tyrosine nitration.
    Hashimoto M, Takada Y, Takeuchi Y, Kasahara J, Hisa H, Shirasaki Y, Fukunaga K.
    J Pharmacol Sci; 2005 Jun 01; 98(2):142-50. PubMed ID: 15937403
    [Abstract] [Full Text] [Related]

  • 11. Post-ischemic administration of DY-9760e, a novel calmodulin antagonist, reduced infarct volume in the permanent focal ischemia model of spontaneously hypertensive rat.
    Takagi K, Sato T, Shirasaki Y, Narita K, Tamura A, Sano K.
    Neurol Res; 2001 Sep 01; 23(6):662-8. PubMed ID: 11547940
    [Abstract] [Full Text] [Related]

  • 12. Protective effect of DY-9760e, a calmodulin antagonist, against neuronal cell death.
    Takano H, Sugimura M, Kanazawa Y, Uchida T, Morishima Y, Shirasaki Y.
    Biol Pharm Bull; 2004 Nov 01; 27(11):1788-91. PubMed ID: 15516724
    [Abstract] [Full Text] [Related]

  • 13. Microsphere embolism-induced endothelial nitric oxide synthase expression mediates disruption of the blood-brain barrier in rat brain.
    Han F, Shirasaki Y, Fukunaga K.
    J Neurochem; 2006 Oct 01; 99(1):97-106. PubMed ID: 16987238
    [Abstract] [Full Text] [Related]

  • 14. Determination of a novel calmodulin antagonist, 3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1- (4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate, DY-9760e, in human plasma using solid-phase extraction and high-performance liquid chromatography with fluorescence detection.
    Tachibana S, Fukano A, Sudo K, Tanaka M.
    J Chromatogr B Biomed Sci Appl; 1999 Oct 29; 734(1):39-45. PubMed ID: 10574188
    [Abstract] [Full Text] [Related]

  • 15. DY-9760e, a novel calmodulin antagonist, reduces infarction after permanent focal cerebral ischemia in rats.
    Sato T, Takamori H, Shirasaki Y.
    Pharmacology; 2004 May 29; 71(1):38-45. PubMed ID: 15051921
    [Abstract] [Full Text] [Related]

  • 16. DY-9760e, a calmodulin antagonist, reduces brain damage after permanent focal cerebral ischemia in cats.
    Sugimura M, Takamori H, Fukushi H, Kitano Y, Kanazawa Y, Shirasaki Y.
    Biol Pharm Bull; 2005 Apr 29; 28(4):629-33. PubMed ID: 15802800
    [Abstract] [Full Text] [Related]

  • 17. DY-9760e, a novel calmodulin antagonist, reduces brain damage induced by transient focal cerebral ischemia.
    Sato T, Morishima Y, Sugimura M, Uchida T, Shirasaki Y.
    Eur J Pharmacol; 1999 Apr 09; 370(2):117-23. PubMed ID: 10323259
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics and disposition of DY-9760e, a novel calmodulin antagonist, in rats and monkeys.
    Tachibana S, Fujimaki Y, Tachibana M, Tanaka M, Kurata T, Okazaki O, Sudo K.
    Arzneimittelforschung; 2005 Apr 09; 55(3):135-44. PubMed ID: 15819385
    [Abstract] [Full Text] [Related]

  • 19. DY-9760e inhibits endothelin-1-induced cardiomyocyte hypertrophy through inhibition of CaMKII and ERK activities.
    Lu YM, Shioda N, Han F, Kamata A, Shirasaki Y, Qin ZH, Fukunaga K.
    Cardiovasc Ther; 2009 Apr 09; 27(1):17-27. PubMed ID: 19207476
    [Abstract] [Full Text] [Related]

  • 20. Protective effect of sulfobutyl ether beta-cyclodextrin on DY-9760e-induced hemolysis in vitro.
    Nagase Y, Hirata M, Arima H, Tajiri S, Nishimoto Y, Hirayama F, Irie T, Uekama K.
    J Pharm Sci; 2002 Nov 09; 91(11):2382-9. PubMed ID: 12379923
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.